TME is a network of clinicians, researchers, educators and companies whose core mission is to improve the quality and access to advanced targeted cancer care by fostering high-quality & comprehensive educational resources and research by synthesizing “State-of-the-Art” with “State-of-the-Science.” Our specialty is breast cancer from prevention, diagnosis, treatment, to survivorship.
TME hosted its Annual Research Reception at The American Society of Breast Surgeons 23rd Annual Meeting in Las Vegas on 8 April 2022. This year’s reception was dedicated to TME Founder, Emeritus, Mark Gittleman MD.
Digistain Launches First International Lab in South Africa
In our ongoing effort to bring accessible cancer diagnostics to the regions that need them most, we are proud to announce the official launch of
